PET Imaging of Carotid Atherosclerosis: Methodology, Implications, and Applications in Neurovascular Disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41084808.
- Also identified by DOI 10.1161/STROKEAHA.125.050399 and PMC identifier 7618311.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Carotid atherosclerosis is a significant cause of incident and recurrent ischemic stroke, with risk not solely related to the degree of luminal stenosis. Multimodal imaging approaches, including positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging, can provide anatomic and molecular evaluation of the atherosclerotic plaque in vivo. Plaque pathophysiology-including the key processes of inflammation and microcalcification-may help characterize stroke risk beyond conventional anatomic assessment alone. This review discusses the use of positron emission tomography in the investigation of carotid atherosclerosis, including methodological considerations, its contributions to our understanding of the underlying disease processes, and how imaging can be used in interventional trials. The clinical implications and potential future applications of positron emission tomography in the assessment and treatment of cerebrovascular disease are also examined.
Medical subject headings
- Carotid Artery Diseases
- Positron-Emission Tomography
- Cerebrovascular Disorders